United-Guardian, Inc. manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products, and specialty industrial products in the United States and internationally. It offers personal care products, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL II XD; ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics; LUBRASLIDE and B-122 powdered lubricants for use in the manufacture of pressed powders, eyeliners, and rouges; KLENSOFT, a surfactant for use in shampoos, shower gels, makeup removers, and other cosmetic formulations; and LUBRASIL, a special form of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base. The company's medical products comprise LUBRAJEL RR and RC lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC, LUBRAJEL FA, and LUBRAJEL BA, which are LUBRAJEL formulations for oral use; LUBRAJEL FLUID to lubricate water-soluble products; and LUBRAJEL TF, a medical lubricant. Its pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder. The company's industrial products include DESELEX liquid, a sequestering and chelating agent for use in the manufacture of detergents; and THOROCLENS, a chlorine-based cleanser. United-Guardian, Inc. also conducts research and product development, primarily related to the development of cosmetic and personal care products. The company markets its products through marketing partners and distributors, advertising in medical and trade journals, mailings to physicians and to the trade, and exhibitions at medical meetings. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
Industry, Sector and Symbol
Industry Toilet preparations
Sub-IndustryN/A
SectorMedical
Phone631-273-0900
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$13.77 million
Profitability
Miscellaneous
Employees23
Next Earnings Date3/19/2020 (Estimated)
OptionableNot Optionable
United-Guardian (NASDAQ:UG) Frequently Asked Questions
What is United-Guardian's stock symbol?
United-Guardian trades on the NASDAQ under the ticker symbol "UG."
How often does United-Guardian pay dividends? What is the dividend yield for United-Guardian?
United-Guardian announced a Semi-Annual dividend on Wednesday, May 15th. Investors of record on Friday, May 31st will be paid a dividend of $0.55 per share on Friday, June 14th. The ex-dividend date is Thursday, May 30th. This is an increase from United-Guardian's previous Semi-Annual dividend of $0.35. View United-Guardian's Dividend History.
How were United-Guardian's earnings last quarter?
United-Guardian, Inc. (NASDAQ:UG) issued its quarterly earnings results on Friday, November, 8th. The company reported $0.23 EPS for the quarter. The company earned $3.32 million during the quarter. United-Guardian had a net margin of 31.01% and a return on equity of 35.13%. View United-Guardian's Earnings History.
When is United-Guardian's next earnings date?
What price target have analysts set for UG?
10 analysts have issued twelve-month price targets for United-Guardian's stock. Their forecasts range from $18.00 to $36.00. On average, they anticipate United-Guardian's stock price to reach $26.95 in the next twelve months. This suggests a possible upside of 42.5% from the stock's current price. View Analyst Price Targets for United-Guardian.
What is the consensus analysts' recommendation for United-Guardian?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for United-Guardian in the last year. There are currently 2 sell ratings, 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for United-Guardian.
Has United-Guardian been receiving favorable news coverage?
News coverage about UG stock has been trending neutral on Friday, according to InfoTrie. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. United-Guardian earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for United-Guardian.
Are investors shorting United-Guardian?
United-Guardian saw a decrease in short interest in the month of October. As of October 31st, there was short interest totalling 4,700 shares, a decrease of 7.8% from the September 30th total of 5,100 shares. Based on an average daily trading volume, of 2,400 shares, the days-to-cover ratio is presently 2.0 days. Currently, 0.2% of the company's stock are short sold. View United-Guardian's Current Options Chain.
Who are some of United-Guardian's key competitors?
Some companies that are related to United-Guardian include Estee Lauder Companies (EL), Colgate-Palmolive (CL), Coty (COTY), Pola Orbis (PORBF), HYPERA S A/S (HYPMY), Inter Parfums (IPAR), Avon Products (AVP), Edgewell Personal Care (EPC), Revlon (REV), Mandom (MDOMF), e.l.f. Beauty (ELF), 2050 Motors (ETFM) and DS Healthcare Group (DSKX).
What other stocks do shareholders of United-Guardian own?
Who are United-Guardian's key executives?
United-Guardian's management team includes the folowing people:
- Mr. Kenneth H. Globus, Pres, Chairman, Principal Exec. Officer & Gen. Counsel (Age 67)
- Mr. Robert S. Rubinger, Exec. VP, Sec. & Director (Age 76)
- Mr. Peter A. Hiltunen, VP & Production Mang. (Age 60)
- Andrea J. Young, Chief Financial Officer, Treasurer & Controller (Age 50)
- Donna Vigilante, R&D Mang. and Director of Technical Services
Who are United-Guardian's major shareholders?
Which institutional investors are selling United-Guardian stock?
How do I buy shares of United-Guardian?
Shares of UG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is United-Guardian's stock price today?
One share of UG stock can currently be purchased for approximately $18.91.
How big of a company is United-Guardian?
What is United-Guardian's official website?
How can I contact United-Guardian?
United-Guardian's mailing address is 230 MARCUS BOULEVARD, HAUPPAUGE NY, 11788. The company can be reached via phone at 631-273-0900.
MarketBeat Community Rating for United-Guardian (NASDAQ UG)
MarketBeat's community ratings are surveys of what our community members think about United-Guardian and other stocks. Vote "Outperform" if you believe UG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UG will underperform the S&P 500 over the long term. You may vote once every thirty days.
